Symbol: |
HHLA3
|
Description: |
HERV-H LTR-associating 3 [Source:HGNC Symbol;Acc:4906]
|
Location: |
Chr1:70820488-70851022[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:159
Gene |
Compound |
Gen_sig |
Exp_pattern |
HHLA3 |
NSC 715471 |
0.012 |
Up |
HHLA3 |
NSC 717469 |
0.036 |
Down |
HHLA3 |
Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- |
0.036 |
Up |
HHLA3 |
NSC 718530 |
0.034 |
Up |
HHLA3 |
NSC 718661 |
0.031 |
Down |
HHLA3 |
11-(5'-Bromopentylidine)-5,6-dihydro-2,3-dimethoxy-6-methyl-8,9-methylenedioxy-5-oxo-11H-indeno[1,2-c]isoquinoline |
0.03 |
Down |
HHLA3 |
NSC 720258 |
0.043 |
Up |
HHLA3 |
NSC 721533 |
0.019 |
Down |
HHLA3 |
NSC 721536 |
0.008 |
Down |
HHLA3 |
2-fluorphenylhydrazone alpha-lapachone |
0.024 |
Down |
HHLA3 |
NSC 722876 |
0.018 |
Up |
HHLA3 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]he xadec-9-ene |
0.047 |
Up |
HHLA3 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.017 |
Up |
HHLA3 |
ARTEMISININ DIMER HEMISUCCINATE |
0.047 |
Up |
HHLA3 |
2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) |
0.006 |
Up |
Expression pattern: Sensitivity / Resistance
Total:11 Current:10
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:11
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:109
Total:8 Current:1
[First] [Prev]  Next Last 
|